JP2024512418A5 - - Google Patents
Info
- Publication number
- JP2024512418A5 JP2024512418A5 JP2023555563A JP2023555563A JP2024512418A5 JP 2024512418 A5 JP2024512418 A5 JP 2024512418A5 JP 2023555563 A JP2023555563 A JP 2023555563A JP 2023555563 A JP2023555563 A JP 2023555563A JP 2024512418 A5 JP2024512418 A5 JP 2024512418A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210042305 | 2021-03-31 | ||
| KR10-2021-0042305 | 2021-03-31 | ||
| PCT/KR2022/004620 WO2022211537A1 (ko) | 2021-03-31 | 2022-03-31 | 신규한 면역 활성 인터루킨 2 아날로그 결합체 및 이의 제조 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512418A JP2024512418A (ja) | 2024-03-19 |
| JP2024512418A5 true JP2024512418A5 (enExample) | 2025-04-10 |
Family
ID=83459706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555563A Pending JP2024512418A (ja) | 2021-03-31 | 2022-03-31 | 新規な免疫活性インターロイキン２アナログ結合体及びその製造方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12599675B2 (enExample) |
| EP (1) | EP4316528A4 (enExample) |
| JP (1) | JP2024512418A (enExample) |
| KR (2) | KR102680146B1 (enExample) |
| CN (1) | CN116916969A (enExample) |
| AR (1) | AR125263A1 (enExample) |
| AU (1) | AU2022209248B2 (enExample) |
| BR (1) | BR112023018530A2 (enExample) |
| CA (1) | CA3205058C (enExample) |
| CL (1) | CL2023002504A1 (enExample) |
| IL (1) | IL304365B2 (enExample) |
| MX (1) | MX2023010926A (enExample) |
| PE (1) | PE20250672A1 (enExample) |
| WO (1) | WO2022211537A1 (enExample) |
| ZA (1) | ZA202307219B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230242607A1 (en) * | 2020-07-09 | 2023-08-03 | Eutilex Co., Ltd. | Il-2 variants |
| CN120475959A (zh) | 2022-12-23 | 2025-08-12 | 韩美药品株式会社 | 包含免疫活性白细胞介素2类似物缀合物的制剂 |
| EP4678180A1 (en) * | 2023-03-07 | 2026-01-14 | Hanmi Pharm. Co., Ltd. | Pharmaceutical composition for preventing or treating cancer including interleukin 2 analog or conjugate thereof |
| WO2024186143A1 (ko) * | 2023-03-07 | 2024-09-12 | 한미약품 주식회사 | 암의 예방 또는 치료를 위한 인터루킨 2 아날로그 또는 이의 결합체 및 면역관문 억제제의 병용 요법 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| KR100507796B1 (ko) * | 2003-04-03 | 2005-08-17 | 한미약품 주식회사 | 생체내 반감기가 증가된 ｐｅｇ-생리활성 폴리펩티드 동종이량체 결합체 및 이의 제조방법 |
| SG192673A1 (en) * | 2011-02-10 | 2013-09-30 | Roche Glycart Ag | Mutant interleukin-2 polypeptides |
| KR102410090B1 (ko) * | 2014-02-21 | 2022-06-16 | 넥타르 테라퓨틱스 (인디아) 프라이빗 리미티드 | 항-ｃｔｌａ－４ 항체 또는 항-ｐｄ－１ 항체와 조합한 ｉｌ－２ｒ베타-선택적 효현제 |
| PT3172227T (pt) * | 2014-07-21 | 2019-12-06 | Delinia Inc | Moléculas que ativam seletivamente células t reguladoras para o tratamento de doenças autoimuneis |
| JP6821560B2 (ja) | 2014-10-21 | 2021-01-27 | サイクロン ファーマシューティカルズ インターナショナル エルティーディー．Ｓｃｉｃｌｏｎｅ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｔｄ． | 免疫刺激剤による癌治療 |
| WO2017052329A1 (en) * | 2015-09-24 | 2017-03-30 | Hanmi Pharm. Co., Ltd. | Protein complex by use of a specific site of an immunoglobulin fragment for linkage |
| JP7422480B2 (ja) * | 2016-05-04 | 2024-01-26 | アムジエン・インコーポレーテツド | 制御性ｔ細胞の増殖のためのインターロイキン－２変異タンパク質 |
| US10696722B2 (en) * | 2016-08-10 | 2020-06-30 | Ajou University Industry-Academic Cooperation Foundation | Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the same |
| EP3538548A4 (en) * | 2016-11-08 | 2020-08-19 | Delinia, Inc. | IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
| KR102777151B1 (ko) * | 2017-11-21 | 2025-03-05 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 인터루킨-2의 부분 효능제 |
| CN111918665B (zh) * | 2018-03-28 | 2024-11-26 | 阿森迪斯药物肿瘤股份有限公司 | Il-2缀合物 |
| MX2021000801A (es) * | 2018-07-24 | 2021-04-12 | BioNTech SE | Agonistas de il2. |
| CA3098930A1 (en) * | 2018-09-21 | 2020-03-26 | Innovent Biologics (Suzhou) Co., Ltd. | Novel interleukin-2 and use thereof |
| EP3901167A4 (en) * | 2018-12-21 | 2022-11-16 | Hanmi Pharm. Co., Ltd. | NOVEL IMMUNOSUPRESSIVE INTERLEUKIN 2 |
| TW202115105A (zh) * | 2019-06-24 | 2021-04-16 | 德商拜恩迪克Ｒｎａ製藥有限公司 | Ｉｌ２激動劑 |
| KR20220044534A (ko) * | 2019-08-13 | 2022-04-08 | 엘피스 바이오파마슈티컬즈 | 조작된 인터류킨-2 수용체 베타 효능제 |
-
2022
- 2022-03-30 IL IL304365A patent/IL304365B2/en unknown
- 2022-03-31 CN CN202280017977.7A patent/CN116916969A/zh active Pending
- 2022-03-31 US US18/000,096 patent/US12599675B2/en active Active
- 2022-03-31 KR KR1020220040626A patent/KR102680146B1/ko active Active
- 2022-03-31 CA CA3205058A patent/CA3205058C/en active Active
- 2022-03-31 MX MX2023010926A patent/MX2023010926A/es unknown
- 2022-03-31 AU AU2022209248A patent/AU2022209248B2/en active Active
- 2022-03-31 AR ARP220100795A patent/AR125263A1/es unknown
- 2022-03-31 JP JP2023555563A patent/JP2024512418A/ja active Pending
- 2022-03-31 EP EP22781656.8A patent/EP4316528A4/en active Pending
- 2022-03-31 BR BR112023018530A patent/BR112023018530A2/pt unknown
- 2022-03-31 PE PE2023002484A patent/PE20250672A1/es unknown
- 2022-03-31 WO PCT/KR2022/004620 patent/WO2022211537A1/ko not_active Ceased
-
2023
- 2023-07-19 ZA ZA2023/07219A patent/ZA202307219B/en unknown
- 2023-08-24 CL CL2023002504A patent/CL2023002504A1/es unknown
-
2024
- 2024-06-14 KR KR1020240077657A patent/KR20240099117A/ko active Pending